Point72 Asset Management’s AstraZeneca AZN Stock Holding History

Point72 Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.03M	Hold	20,450	–	–	0.01%	1853
2025 Q4	$3.76M	Buy	20,450 +6,800	+50%	+$1.19M	﹤0.01%	2040
2025 Q3	$2.09M	Hold	13,650	–	–	﹤0.01%	1426
2025 Q2	$1.91M	Buy	+13,650	New	+$1.91M	﹤0.01%	1327
2024 Q4	–	Sell	-75,000	Closed	-$11.7M	–	2080
2024 Q3	$11.7M	Buy	+75,000	New	+$12.1M	0.03%	593
2023 Q1	–	Sell	-14,100	Closed	-$1.91M	–	2231
2022 Q4	$1.91M	Buy	+14,100	New	+$1.77M	0.01%	940
2022 Q3	–	Sell	-3,600	Closed	-$476K	–	1403
2022 Q2	$476K	Buy	+3,600	New	+$472K	﹤0.01%	1196

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Point72 Asset Management's AZN Position: Q1 2026 in Review

Point72 Asset Management increased its AstraZeneca (AZN) stake by 33% in Q1 2026, buying an estimated $59.3M and bringing the position to 1,233,965 shares worth $243M. The position accounts for 0.31% of the portfolio, ranked #37.

Point72 Asset Management first reported a position in AZN in Q2 2014 and has held it in 36 quarters since. The position peaked at $264M in Q3 2022. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Point72 Asset Management held 1,233,965 shares of AstraZeneca worth $243M as of Q1 2026.
Point72 Asset Management bought 307,594 AstraZeneca shares in Q1 2026, an estimated $59.3M.
AstraZeneca made up 0.31% of Point72 Asset Management's portfolio in Q1 2026, its #37 holding.
Point72 Asset Management first reported a position in AstraZeneca in Q2 2014 and has held it in 36 quarters since.
Point72 Asset Management's AstraZeneca position peaked at $264M in Q3 2022.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.